Nacuity Pharmaceuticals
Fort Worth, US · Founded 2016 · Delaware corporation · 1 known investors
Based on the page listing "Ophthalmic Pharmaceutical Consultant" and "Chief Clinical Officer" roles, Nacuity appears to be a pharmaceutical company focused on ophthalmology (eye care), though the page provides insufficient detail to confirm products, customer base, or market focus.
Founders & leadership
MW
Michael WallinSVP & CSO
DW
David WohlbergExecutive
JK
Jami KerninSr. Vice President, Chief Clinical Officer
HC
Halden ConnerinCEO/President
CL
Charles LieserExecutive
CL
Carol LakkisinDirector/R&D Technical Director
Board
EC
Emmett Cunningham, Jr.Board director
RS
Robin SteeleBoard director
RK
Rusty KelleyBoard director
GC
Gerald CagleBoard director
BY
Benjamin YerxaBoard director
Investors · 1
Funding
SEC filings, press & company announcements$31.2M disclosed across 4 of 5 rounds · 2016–2025
- Undisclosed amountSeries BJun 2022Source ↗
▶$8.4MraisedDec 2025 · 98 investors · PharmaceuticalsRule 506(b)
▶$8.4MraisedDec 2025 · 98 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael WallExecutive Officer
- Robin SteeleDirector
- David WohlbergExecutive Officer, Director
- Rusty KelleyDirector
- Gerald CagleDirector
- Jami KernExecutive Officer
- Benjamin YerxaDirector
- Emmett Cunningham, Jr.Director
- Halden ConnerExecutive Officer, Director
- Charles LieserExecutive Officer
- Offering amount
- $30M
- Amount sold
- $8.4M
- Minimum investment
- $9.4K
- Sales commissions
- $839.3K
- Placement agents
- Maxim Group LLC
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.6MraisedJan 2022 · 144 investors · BiotechnologyRule 506(b)
▶$11.6MraisedJan 2022 · 144 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David WohlbergExecutive Officer, Director
- Charles LieserExecutive Officer
- Halden ConnerExecutive Officer, Director
- Robert RuffoloDirector
- Robin SteelDirector
- Benjamin YerxaDirector
- Gerald CagleDirector
- Offering amount
- $17.4M
- Amount sold
- $11.6M
- Minimum investment
- $10K
- Sales commissions
- $1.4M
- Placement agents
- Clifford Adam Teller
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.2MraisedJul 2017 · 125 investors · BiotechnologyRule 506(b)
▶$9.2MraisedJul 2017 · 125 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Isaac BlechDirector
- Charles LieserExecutive Officer
- G. Michael Wall, Ph.D.Executive Officer
- Dr. Gerald D. CagleDirector
- David J. WohlbergDirector
- William Halden ConnerExecutive Officer, Director
- Richard Chin, M.D.Director
- Sanford HillsbergDirector
- Offering amount
- $10M
- Amount sold
- $9.2M
- Minimum investment
- $25K
- Sales commissions
- $922.7K
- Placement agents
- Clifford Adam Teller
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$2MraisedDec 2016 · 46 investors · PharmaceuticalsRule 506(b)
▶$2MraisedDec 2016 · 46 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- William Halden ConnerExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2M
- Minimum investment
- $10K
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Nacuity Pharmaceuticals do?
- Based on the page listing "Ophthalmic Pharmaceutical Consultant" and "Chief Clinical Officer" roles, Nacuity appears to be a pharmaceutical company focused on ophthalmology (eye care), though the page provides insufficient detail to confirm products, customer base, or market focus.
- Who are Nacuity Pharmaceuticals's investors?
- Nacuity Pharmaceuticals's investors include Tarnagulla Ventures.
- How much funding has Nacuity Pharmaceuticals raised?
- Nacuity Pharmaceuticals has disclosed $31.2M raised across 4 of its 5 known rounds.
- Where is Nacuity Pharmaceuticals headquartered?
- Nacuity Pharmaceuticals is headquartered in Fort Worth, US.